These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23603784)

  • 21. Clinical outcome of HCV-related graft cirrhosis and prognostic value of hepatic venous pressure gradient.
    Kalambokis G; Manousou P; Samonakis D; Grillo F; Dhillon AP; Patch D; O'Beirne J; Rolles K; Burroughs AK
    Transpl Int; 2009 Feb; 22(2):172-81. PubMed ID: 18786149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-invasive aspartate aminotransferase to platelet ratio index correlates well with invasive hepatic venous pressure gradient in cirrhosis.
    Kirnake V; Arora A; Sharma P; Goyal M; Chawlani R; Toshniwal J; Kumar A
    Indian J Gastroenterol; 2018 Jul; 37(4):335-341. PubMed ID: 30178093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic Venous Pressure Gradient Predicts Long-Term Mortality in Patients with Decompensated Cirrhosis.
    Kim TY; Lee JG; Sohn JH; Kim JY; Kim SM; Kim J; Jeong WK
    Yonsei Med J; 2016 Jan; 57(1):138-45. PubMed ID: 26632394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy of biomarkers measured in the hepatic vein and peripheral vein in the prediction of advanced fibrosis in patients with chronic viral hepatitis.
    Suk KT; Kim DJ; Kim CH; Park SH; Cheong JY; Cho SW; Choi JY; Han KH; Sung HT; Hong SH; Kim DY; Yoon JH; Kim YS; Baik GH; Kim JB
    Clin Biochem; 2012 Sep; 45(13-14):1075-80. PubMed ID: 22579966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis.
    Kim MY; Suk KT; Baik SK; Kim HA; Kim YJ; Cha SH; Kwak HR; Cho MY; Park HJ; Jeon HK; Park SY; Kim BR; Hong JH; Jo KW; Kim JW; Kim HS; Kwon SO; Chang SJ; Baik GH; Kim DJ
    Hepatology; 2012 Sep; 56(3):1053-62. PubMed ID: 22473911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension.
    Manolakopoulos S; Triantos C; Theodoropoulos J; Vlachogiannakos J; Kougioumtzan A; Papatheodoridis G; Tzourmakliotis D; Karamanolis D; Burroughs AK; Archimandritis A; Raptis S; Avgerinos A
    J Hepatol; 2009 Sep; 51(3):468-74. PubMed ID: 19616339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced fibrosis.
    Rincon D; Ripoll C; Lo Iacono O; Salcedo M; Catalina MV; Alvarez E; Nuñez O; Matilla AM; Clemente G; Bañares R
    Am J Gastroenterol; 2006 Oct; 101(10):2269-74. PubMed ID: 17032192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.
    Lee KG; Seo YS; An H; Um SH; Jung ES; Keum B; Yim HJ; Jeen YT; Chun HJ; Kim CD; Ryu HS
    J Gastroenterol Hepatol; 2010 Jan; 25(1):94-100. PubMed ID: 19793171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis.
    Park SH; Park TE; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1289-93. PubMed ID: 19682196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis.
    Reverter E; Blasi A; Abraldes JG; Martínez-Palli G; Seijo S; Turon F; Berzigotti A; Balust J; Bosch J; García-Pagán JC
    Liver Int; 2014 Jan; 34(1):16-25. PubMed ID: 23763484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations.
    Tseng PL; Wang JH; Hung CH; Tung HD; Chen TM; Huang WS; Liu SL; Hu TH; Lee CM; Lu SN
    Kaohsiung J Med Sci; 2013 Jul; 29(7):385-95. PubMed ID: 23768703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study.
    Colecchia A; Colli A; Casazza G; Mandolesi D; Schiumerini R; Reggiani LB; Marasco G; Taddia M; Lisotti A; Mazzella G; Di Biase AR; Golfieri R; Pinzani M; Festi D
    J Hepatol; 2014 Jun; 60(6):1158-64. PubMed ID: 24607624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting.
    Lesmana CR; Salim S; Hasan I; Sulaiman AS; Gani RA; Pakasi LS; Lesmana LA; Krisnuhoni E; Budihusodo U
    J Clin Pathol; 2011 Oct; 64(10):916-20. PubMed ID: 21670074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A practical scoring system for predicting cirrhosis in patients with chronic viral hepatitis.
    Cheong JY; Um SH; Seo YS; Shin SS; Park RW; Kim DJ; Hwang SG; Lee YJ; Cho M; Yang JM; Kim YB; Park YN; Cho SW
    Hepatogastroenterology; 2012; 59(120):2592-7. PubMed ID: 23178625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW; Huo TI; Yang YY; Hou MC; Lee PC; Lin HC; Lee FY; Chi CW; Lee SD
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation.
    Blasco A; Forns X; Carrión JA; García-Pagán JC; Gilabert R; Rimola A; Miquel R; Bruguera M; García-Valdecasas JC; Bosch J; Navasa M
    Hepatology; 2006 Mar; 43(3):492-9. PubMed ID: 16496308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Decompensation and Outcomes in Patients With Compensated Cirrhosis and a Hepatic Venous Pressure Gradient ≥20 mm Hg.
    Jindal A; Bhardwaj A; Kumar G; Sarin SK
    Am J Gastroenterol; 2020 Oct; 115(10):1624-1633. PubMed ID: 32453061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C.
    Luo JC; Hwang SJ; Chang FY; Chu CW; Lai CR; Wang YJ; Lee PC; Tsay SH; Lee SD
    Hepatogastroenterology; 2002; 49(44):478-81. PubMed ID: 11995477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection.
    Ma J; Jiang Y; Gong G
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):428-34. PubMed ID: 23358121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B].
    Chen YP; Feng XR; Dai L; Ding HB; Zhang L
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):225-7. PubMed ID: 12716522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.